Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 159.982K |
Day Range | - - - |
52 Wk Range | 2.700 - 9.970 |
Market Cap | $218.363M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 4.12% |
Days to Cover | 16.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.
Other companies in Foghorn Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Tevogen Bio Holdings (NASDAQ:TVGN) and Design Therapeutics (NASDAQ:DSGN).
The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by Wedbush on Wednesday, April 10, 2024. The analyst firm set a price target for 13.00 expecting FHTX to rise to within 12 months (a possible 153.41% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $5.13 last updated April 24, 2024 at 4:30 PM EDT.
There are no upcoming dividends for Foghorn Therapeutics.
Foghorn Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Foghorn Therapeutics.
Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.